A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM)
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab (MK-3475) in MM Patients With Residual Disease
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2